Skip to main content
Erschienen in: Annals of Surgical Oncology 6/2019

12.03.2019 | Thoracic Oncology

Effect of Resection of the Thoracic Duct and Surrounding Lymph Nodes on Short- and Long-Term and Nutritional Outcomes After Esophagectomy for Esophageal Cancer

verfasst von: Naoya Yoshida, MD, PhD, Yohei Nagai, MD, PhD, Yoshifumi Baba, MD, PhD, Yuji Miyamoto, MD, PhD, Shiro Iwagami, MD, PhD, Masaaki Iwatsuki, MD, PhD, Yukiharu Hiyoshi, MD, PhD, Kojiro Eto, MD, PhD, Takatsugu Ishimoto, MD, PhD, Yuki Kiyozumi, MD, PhD, Daichi Nomoto, MD, Takahiko Akiyama, MD, Yu Imamura, MD, PhD, Masayuki Watanabe, MD, PhD, Hideo Baba, MD, PhD

Erschienen in: Annals of Surgical Oncology | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

The effect of resection of the thoracic duct (TD) along with surrounding lymph nodes (LN) on short- and long-term outcomes of esophagectomy in esophageal cancer patients is not well defined.

Methods

A total of 537 consecutive patients suffering from esophageal cancer who underwent three-incision esophagectomy between April 2005 and August 2018 were eligible for short-term outcome analysis. Among them, 487 patients who underwent surgery before August 2017 were eligible for analysis of long-term outcomes. Moreover, 164 patients who underwent esophagectomy after August 2012 and had no recurrence at 1-year postoperative follow-up were prospectively investigated for postoperative nutritional status.

Results

A total of 145 patients (27.0%) underwent TD resection with surrounding LN. Since the clinical stage was significantly more advanced in the removal group, preoperative treatment was more frequently performed in them. The operative time was significantly longer in the removal group. Intraoperative bleeding was higher in the removal group. Morbidity of Clavien–Dindo classification (CDc) ≥ II and pulmonary morbidities were frequently observed in the removal group. Multivariate analysis suggested that TD resection was an independent risk factor for pulmonary morbidities. Moreover, it may be associated with the incidence of CDc ≥ II morbidity. Greater numbers of LN were dissected in the thorax of patients in the removal group. However, overall survival was equivalent irrespective of the TD procedure in each stage. Nutritional status at 1-year follow-up was equivalent between the groups.

Conclusions

On the basis of the present results, routine removal of the TD during esophagectomy is not recommended.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Schurink B, Defize IL, Mazza E, Ruurda JP, Brosens LAA, Roeling TAP, Bleys RLAW, et al. Two-field lymphadenectomy during esophagectomy: the presence of thoracic duct lymph nodes. Ann Thorac Surg. 2018;106(2):435–9.CrossRefPubMed Schurink B, Defize IL, Mazza E, Ruurda JP, Brosens LAA, Roeling TAP, Bleys RLAW, et al. Two-field lymphadenectomy during esophagectomy: the presence of thoracic duct lymph nodes. Ann Thorac Surg. 2018;106(2):435–9.CrossRefPubMed
2.
Zurück zum Zitat Anand S, Kalayarasan R, Chandrasekar S, Gnanasekaran S, Pottakkat B. Minimally invasive esophagectomy with thoracic duct resection post neoadjuvant chemoradiotherapy for carcinoma esophagus-impact on lymph node yield and hemodynamic parameters. J Gastrointest Cancer. 2018. https://doi.org/10.1007/s12029-018-0051-1.CrossRef Anand S, Kalayarasan R, Chandrasekar S, Gnanasekaran S, Pottakkat B. Minimally invasive esophagectomy with thoracic duct resection post neoadjuvant chemoradiotherapy for carcinoma esophagus-impact on lymph node yield and hemodynamic parameters. J Gastrointest Cancer. 2018. https://​doi.​org/​10.​1007/​s12029-018-0051-1.CrossRef
3.
Zurück zum Zitat Imamura M, Shimada Y, Kanda T, Miyahara T, Hashimoto M, Tobe T, Arai T, et al. Hemodynamic changes after resection of thoracic duct for en bloc resection of esophageal cancer. Surg Today. 1992;22(3):226–32.CrossRefPubMed Imamura M, Shimada Y, Kanda T, Miyahara T, Hashimoto M, Tobe T, Arai T, et al. Hemodynamic changes after resection of thoracic duct for en bloc resection of esophageal cancer. Surg Today. 1992;22(3):226–32.CrossRefPubMed
4.
Zurück zum Zitat Takeno A, Tamura S, Miki H, Tanigawa N, Taniguchi H, Nakahira S, Suzuki R, et al. Chyluria after ligation of the thoracic duct: a rare complication after thoracoscopic-assisted esophagectomy for esophageal cancer. Surg Today. 2014;44(4):757–60.CrossRefPubMed Takeno A, Tamura S, Miki H, Tanigawa N, Taniguchi H, Nakahira S, Suzuki R, et al. Chyluria after ligation of the thoracic duct: a rare complication after thoracoscopic-assisted esophagectomy for esophageal cancer. Surg Today. 2014;44(4):757–60.CrossRefPubMed
5.
Zurück zum Zitat Aiko S, Yoshizumi Y, Matsuyama T, Sugiura Y, Maehara T. Influences of thoracic duct blockage on early enteral nutrition for patients who underwent esophageal cancer surgery. Jpn J Thorac Cardiovasc Surg. 2003;51(7):263–71.CrossRefPubMed Aiko S, Yoshizumi Y, Matsuyama T, Sugiura Y, Maehara T. Influences of thoracic duct blockage on early enteral nutrition for patients who underwent esophageal cancer surgery. Jpn J Thorac Cardiovasc Surg. 2003;51(7):263–71.CrossRefPubMed
7.
Zurück zum Zitat Sobin LH, Gospodarowicz MK, Wittekind C. International Union against Cancer: TNM classification of malignant tumours. 7th ed. Hoboken: Wiley; 2010. Sobin LH, Gospodarowicz MK, Wittekind C. International Union against Cancer: TNM classification of malignant tumours. 7th ed. Hoboken: Wiley; 2010.
8.
Zurück zum Zitat Society of Thoracic Surgeons General Thoracic Surgery Database Task Force. The Society of Thoracic Surgeons composite score for evaluating esophagectomy for esophageal cancer. Ann Thorac Surg. 2017;103(5):1661–7.CrossRef Society of Thoracic Surgeons General Thoracic Surgery Database Task Force. The Society of Thoracic Surgeons composite score for evaluating esophagectomy for esophageal cancer. Ann Thorac Surg. 2017;103(5):1661–7.CrossRef
9.
Zurück zum Zitat Yoshida N, Baba Y, Shigaki H, Harada K, Iwatsuki M, Kurashige J, Sakamoto Y, et al. Preoperative nutritional assessment by controlling nutritional status (CONUT) is useful to estimate postoperative morbidity after esophagectomy for esophageal cancer. World J Surg. 2018;40(8):1910–7.CrossRef Yoshida N, Baba Y, Shigaki H, Harada K, Iwatsuki M, Kurashige J, Sakamoto Y, et al. Preoperative nutritional assessment by controlling nutritional status (CONUT) is useful to estimate postoperative morbidity after esophagectomy for esophageal cancer. World J Surg. 2018;40(8):1910–7.CrossRef
10.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–13.CrossRefPubMedPubMedCentral Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–13.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Sathornviriyapong S, Matsuda A, Miyashita M, Matsumoto S, Sakurazawa N, Kawano Y, Yamada M, et al. Impact of neoadjuvant chemoradiation on short-term outcomes for esophageal squamous cell carcinoma patients: a meta-analysis. Ann Surg Oncol. 2016;23(11):3632–40.CrossRefPubMed Sathornviriyapong S, Matsuda A, Miyashita M, Matsumoto S, Sakurazawa N, Kawano Y, Yamada M, et al. Impact of neoadjuvant chemoradiation on short-term outcomes for esophageal squamous cell carcinoma patients: a meta-analysis. Ann Surg Oncol. 2016;23(11):3632–40.CrossRefPubMed
12.
Zurück zum Zitat Kumagai K, Rouvelas I, Tsai JA, Mariosa D, Klevebro F, Lindblad M, Ye W, et al. Meta-analysis of postoperative morbidity and perioperative mortality in patients receiving neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal and gastro-oesophageal junctional cancers. Br J Surg. 2014;101(4):321–38.CrossRefPubMed Kumagai K, Rouvelas I, Tsai JA, Mariosa D, Klevebro F, Lindblad M, Ye W, et al. Meta-analysis of postoperative morbidity and perioperative mortality in patients receiving neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal and gastro-oesophageal junctional cancers. Br J Surg. 2014;101(4):321–38.CrossRefPubMed
13.
Zurück zum Zitat Crucitti P, Mangiameli G, Petitti T, Condoluci A, Rocco R, Gallo IF, Longo F, et al. Does prophylactic ligation of the thoracic duct reduce chylothorax rates in patients undergoing oesophagectomy? A systematic review and meta-analysis. Eur J Cardiothorac Surg. 2016;50(6):1019–24.CrossRefPubMed Crucitti P, Mangiameli G, Petitti T, Condoluci A, Rocco R, Gallo IF, Longo F, et al. Does prophylactic ligation of the thoracic duct reduce chylothorax rates in patients undergoing oesophagectomy? A systematic review and meta-analysis. Eur J Cardiothorac Surg. 2016;50(6):1019–24.CrossRefPubMed
14.
Zurück zum Zitat Lai FC, Chen L, Tu YR, Lin M, Li X. Prevention of chylothorax complicating extensive esophageal resection by mass ligation of thoracic duct: a random control study. Ann Thorac Surg. 2011;91(6):1770–4.CrossRefPubMed Lai FC, Chen L, Tu YR, Lin M, Li X. Prevention of chylothorax complicating extensive esophageal resection by mass ligation of thoracic duct: a random control study. Ann Thorac Surg. 2011;91(6):1770–4.CrossRefPubMed
15.
Zurück zum Zitat Matsuda S, Takeuchi H, Kawakubo H, Shimada A, Fukuda K, Nakamura R, Takahashi T, et al. Clinical outcome of transthoracic esophagectomy with thoracic duct resection: number of dissected lymph node and distribution of lymph node metastasis around the thoracic duct. Medicine. 2016;95(24):e3839.CrossRefPubMedPubMedCentral Matsuda S, Takeuchi H, Kawakubo H, Shimada A, Fukuda K, Nakamura R, Takahashi T, et al. Clinical outcome of transthoracic esophagectomy with thoracic duct resection: number of dissected lymph node and distribution of lymph node metastasis around the thoracic duct. Medicine. 2016;95(24):e3839.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Sasako M, Sano T, Yamamoto S, Kurokawa Y, Nashimoto A, Kurita A, Hiratsuka M, et al. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med. 2008;359(5):453–62.CrossRefPubMed Sasako M, Sano T, Yamamoto S, Kurokawa Y, Nashimoto A, Kurita A, Hiratsuka M, et al. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med. 2008;359(5):453–62.CrossRefPubMed
17.
Zurück zum Zitat Baba Y, Yoshida N, Shigaki H, Iwatsuki M, Miyamoto Y, Sakamoto Y, Watanabe M, et al. Prognostic impact of postoperative complications in 502 patients with surgically resected esophageal squamous cell carcinoma: a retrospective single-institution study. Ann Surg. 2016;264(2):305–11.CrossRefPubMed Baba Y, Yoshida N, Shigaki H, Iwatsuki M, Miyamoto Y, Sakamoto Y, Watanabe M, et al. Prognostic impact of postoperative complications in 502 patients with surgically resected esophageal squamous cell carcinoma: a retrospective single-institution study. Ann Surg. 2016;264(2):305–11.CrossRefPubMed
19.
Zurück zum Zitat Yamasaki M, Miyata H, Yasuda T, Shiraishi O, Takahashi T, Motoori M, Yano M, et al. Impact of the route of reconstruction on post-operative morbidity and malnutrition after esophagectomy: a multicenter cohort study. World J Surg. 2015;39(2):433–40.CrossRefPubMed Yamasaki M, Miyata H, Yasuda T, Shiraishi O, Takahashi T, Motoori M, Yano M, et al. Impact of the route of reconstruction on post-operative morbidity and malnutrition after esophagectomy: a multicenter cohort study. World J Surg. 2015;39(2):433–40.CrossRefPubMed
Metadaten
Titel
Effect of Resection of the Thoracic Duct and Surrounding Lymph Nodes on Short- and Long-Term and Nutritional Outcomes After Esophagectomy for Esophageal Cancer
verfasst von
Naoya Yoshida, MD, PhD
Yohei Nagai, MD, PhD
Yoshifumi Baba, MD, PhD
Yuji Miyamoto, MD, PhD
Shiro Iwagami, MD, PhD
Masaaki Iwatsuki, MD, PhD
Yukiharu Hiyoshi, MD, PhD
Kojiro Eto, MD, PhD
Takatsugu Ishimoto, MD, PhD
Yuki Kiyozumi, MD, PhD
Daichi Nomoto, MD
Takahiko Akiyama, MD
Yu Imamura, MD, PhD
Masayuki Watanabe, MD, PhD
Hideo Baba, MD, PhD
Publikationsdatum
12.03.2019
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 6/2019
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-019-07304-z

Weitere Artikel der Ausgabe 6/2019

Annals of Surgical Oncology 6/2019 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.